InvestorsHub Logo
Followers 185
Posts 2462
Boards Moderated 0
Alias Born 02/10/2017

Re: None

Wednesday, 02/17/2021 7:16:06 AM

Wednesday, February 17, 2021 7:16:06 AM

Post# of 116
SURF they have 6 very promising antibody molecules.

GSK puts up to $815M on the table for Surface Oncology's antibody.
https://www.fiercebiotech.com/biotech/gsk-puts-up-to-815m-table-for-surface-oncology-s-antibody

Surface Oncology (SURF) Explores Potential Sale After GSK Takeover Approach - Source
https://www.streetinsider.com/Hot+M+and+A/Surface+Oncology+%28SURF%29+Explores+Potential+Sale+After+GSK+Takeover+Approach+-+Source/17458243.html

Cathie Wood from ARKG has been buying SURF everyday a million share purchase in one day a few weeks back.

2021/2/16
ARKG 3,883,960 (+35,028)
9.55% of outstanding shares.

Novartis 9.71% holding.

Eli Lily holds 8.5% through LLV ventures fund.


Cash runway into 2023

Licensing agreements with $NVS $GSK and $MRK??


SRF617 (100% OWNED) - Targets CD39
SRF388 (100% OWNED) - Targets IL27
SRF813 (GSK 830M DEAL) - Targets PVRIG
NZV930 (Deal with Novartis)
SRF114 Targets CCR8


Cup and handle forming on the weekly!
Take a look at this chart get in before the pop to $15-$20
https://stockcharts.com/h-sc/ui?s=surf


$SURF


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SURF News